The medicine "Eufillin" is widely used in medical practice. In particular, the drug is prescribed for cardiovascular, pulmonary pathologies. An effective remedy for circulatory disorders.
Describing the drug "Eufillin" (tablets), the instructions for use indicate its ability to dilate blood vessels, improving their permeability.
In the treatment of lung diseases, the drug facilitates the separation of sputum, effectively relieves shortness of breath. The drug "Eufillin" is recommended to use to relieve bronchospasm. The tool is able to affect the muscles of the respiratory organs, reducing contractility. The drug "Eufillin" is effective for relieving spasms not only in the bronchi, but also in the blood vessels and bile ducts.
The medication has the ability to suspend the transport of calcium ions through the channels of cell membranes.
The drug "Eufillin" (tablets), instructions for use indicate this, has a moderate diuretic (diuretic) effect, reduces platelet aggregation. The medication has a stimulating effect on the respiratory center, increases the strength and frequency of heart contractions.
The bioavailability of the drug when taken orally is eighty-one hundred percent. The medication binds to plasma proteins by approximately 60%. Means "Eufillin" (tablets), instructions for use contain such information, almost completely (ninety percent) is metabolized in the liver. The half-life is from five hours to one day.
Means "Eufillin" (tablets), the instruction for use recommends for bronchial obstructive syndrome, a disorder of the respiratory center. As part of a combination treatment, a medication is prescribed for circulatory failure and circulatory disorders of the brain.
Dosage is set individually. As a rule, one or two tablets of the “Eufillin” remedy are recommended three to four times a day. If necessary (as prescribed by the doctor), the dosage may be increased at intervals of two to three days until the necessary therapeutic effectiveness is achieved.
When using the drug, a decrease in appetite is likely. Headache, nausea, tachycardia, vomiting, heart rhythm disorder , albuminuria may occur. In some cases, hematuria was noted while taking the medicine. Allergic reactions (rash or itching) are also considered likely side effects. In rare cases, hypoglycemia, an exacerbation of an ulcer, and a convulsive state may occur.
Means "Eufillin" is contraindicated in angina pectoris, acute heart failure, heart rhythm disorders, epilepsy. A medication is not recommended for violations in the activity of the kidneys or liver of a pronounced nature, hypersensitivity to aminophylline.
Caution should be observed when prescribing the drug "Eufillin" to patients with fever of an unclear nature, patients in old age.
It was found that the medication can increase the content of uric acid in the urine.
The use of the drug "Eufillin" during gestation and feeding is allowed only according to indications. In this case, the appointment is carried out only by a doctor. The specialist should monitor the condition of pregnant and lactating patients throughout the entire therapeutic course.
With the simultaneous use of the drug "Eufillin" with the preparations "Salbutamol" and "Terbutaline", their bronchodilating activity is enhanced.
The combined use of the drug with beta-blockers can provoke bronchospasm.
Means "Eufillin". Release form
The drug is made in the form of a solution for injection (both intravenous and intramuscular). Eufillin tablets and suppositories are available.
Before using the product, consult a doctor.